GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's quarterly accounts payable declined from Mar. 2014 ($14,400 Mil) to Jun. 2014 ($13,814 Mil) but then increased from Jun. 2014 ($13,814 Mil) to Sep. 2014 ($14,373 Mil).
GlaxoSmithKline PLC's annual accounts payable increased from Dec. 2011 ($14,044 Mil) to Dec. 2012 ($15,231 Mil) and increased from Dec. 2012 ($15,231 Mil) to Dec. 2013 ($15,715 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data